POL humane challenge

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
Zeile 31: Zeile 31:
 
{{tp|p=33236048|t=2020. Challenge Trials: What Are the Ethical Problems?|pdf=|usr=021}}
 
{{tp|p=33236048|t=2020. Challenge Trials: What Are the Ethical Problems?|pdf=|usr=021}}
 
{{tp|p=33249450|t=2020. Assessment of risks associated with SARS-CoV-2 experimental human infection studies.|pdf=|usr=021}}
 
{{tp|p=33249450|t=2020. Assessment of risks associated with SARS-CoV-2 experimental human infection studies.|pdf=|usr=021}}
 +
{{tp|p=C7598752|t=?. Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.|pdf=|usr=023}}

Version vom 2. Januar 2021, 09:54 Uhr

Politics main page
POL research ethics
Nuremberg was for nazis only and UK is not Europe


32218549 2020. Should scientists infect healthy people with the coronavirus to test vaccines?
32241929 2020. Infect volunteers to speed a coronavirus vaccine?
32322034 2020. Hundreds of people volunteer to be infected with coronavirus.
32461245 2020. Ethical guidelines for deliberately infecting volunteers with COVID-19.
32469074 2020. Paying Participants in COVID-19 Trials.
32414757 2020. Ethical considerations for epidemic vaccine trials.
32479747 2020. COVID-19 human challenge studies: ethical issues.
32496536 2020. SARS-CoV-2 Human Challenge Trials: Too Risky, Too Soon.
32635912 2020. Exploring the acceptability of controlled human infection with SARSCoV2-a public consultation.
32669462 2020. Human Infection Challenge Studies: a Test for the Social Value Criterion of Research Ethics.
32616623 2020. Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.
32795408 2020. Evolving ethics of COVID-19 challenge trials.
32851596 2020. COVID-19 vaccines: ethical framework concerning human challenge studies.
32829985 2020. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.
32840856 2020. Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks.
33046591 2020. Payment of COVID-19 challenge trials: underpayment is a bigger worry than overpayment.
32978304 2020. SARS-CoV-2 challenge studies: ethics and risk minimisation.
32978306 2020. Payment in challenge studies: ethics, attitudes and a new payment for risk model.
33082550 2020. Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.
33087558 2020. Opinion: A risk-benefit framework for human research during the COVID-19 pandemic.
33087904 2020. Immunological considerations for SARS-CoV-2 human challenge studies.
33122444 2020. Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
33137284 2020. COVID-19 human challenge studies in the UK.
33154089 2020. Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants?
33235368 2020. The COVID vaccine challenges that lie ahead.
33236048 2020. Challenge Trials: What Are the Ethical Problems?
33249450 2020. Assessment of risks associated with SARS-CoV-2 experimental human infection studies.
C7598752 ?. Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.

Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis